Hybrid Pharma is a leader in formulating high quality sterile and non-sterile pharmaceutical compounds for human and animal use. As an FDA outsourcing facility, we can manufacture medications in a limited quantity when they are in shortage. Our cleanroom exceeds the USP requirements and our quality control laboratory is equipped with state-of-the-art testing equipments for which we follow cGMP guidelines.
We have expertise and experience in modifying existing formulations and developing new formulations for better stability and bioavailability. Using our skills and expertise, our mission is to provide medications of the highest quality and purity to the healthcare industry.
We have expertise and experience in modifying existing formulations and developing new formulations for better stability and bioavailability. Using our skills and expertise, our mission is to provide medications of the highest quality and purity to the healthcare industry.
Services
Hybrid Pharma is able to provide the healthcare industry with various sterile and non-sterile compounded medications. Our experience and expertise allows us to formulate and deliver these medications to healthcare providers and we contribute to the overall wellness of the patient. Over the years Hybrid Pharma developed, tested and marketed several sterile as well as non sterile pharmaceutical formulations.
Our experience with cGMP focused processes as well as carefully designed facilities, equipment, training and testing provides confidence to our customers in the quality of our services. Finished drug products undergo extensive quality testing for strength, quality, and purity. We utilize both in-house and outsourced laboratories for analytical testing.
We are constantly researching and developing innovative methodology to maximize efficiency and accuracy in the lab. All the potential methods and procedures pass a critical validation criterion before being incorporated into our work flow. Utilization of a team of scientists and pharmacists with an extensive background in pharmaceutical chemistry, formulation development and process development.
Reviews (1)
Daniel
Aug 31, 2020
Report
